Roy Blum, PhD


Investigator, Other (M)
Molecular Biology, Mass General Research Institute
Research Associate in Genetics
Harvard Medical School
brain tumors; drug development; epigenetics; gene therapy; immune-oncology; leukemia; myogenic disorders; neuroendocrine tumors; oncology; prostate cancer; stem cells Extensive scientific knowledge in oncology (leukemia, brain, prostate, and neuroendocrine tumors), immune-oncology, drug development, myogenic disorders, gene therapy, stem cells, and epigenetics.